Please enable JavaScript to continue using this application.

Compare $HRGN vs $LITS | Chartloom

Compare

$HRGN vs $LITS

Harvard Apparatus Regenerative Technology Inc · Lite Strategy Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

LITS

Lite Strategy Inc

Compare $HRGN vs $LITS

Comparing Harvard Apparatus Regenerative Technology Inc and Lite Strategy Inc

HRGNHarvard Apparatus Regenerative Technology Inc

LITSLite Strategy Inc

HRGNHarvard Apparatus Regenerative Technology Inc

Market cap

$40M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

44.6%

YTD performance

16.2%

52W performance

-15.8%

FCF yield

-9.0%

LITSLite Strategy Inc

Market cap

$43M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-17.5%

52W performance

-49.2%

FCF yield

-21.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HRGN

LITS

Detailed metrics comparison

HRGN

Harvard Apparatus Regenerative Technology Inc

LITS

Lite Strategy Inc

Market Cap

HRGN$40M

LITS$43M

Enterprise Value

HRGN$41M

LITS$38M

Price

HRGN$2.30

LITS$1.27

P/E Ratio

HRGNN/A

LITSN/A

P/S Ratio

HRGN41.18x

LITS0.40x

EV/Sales

HRGN41.33x

LITS0.00x

EV/EBITDA

HRGN0.00x

LITS0.00x

P/B Ratio

HRGN507.11x

LITS1.01x

P/FCF Ratio

HRGNN/A

LITSN/A

EV/FCF

HRGN-11.16x

LITS-4.11x

PEG Ratio

HRGNN/A

LITSN/A

Forward P/E (NTM)

HRGNN/A

LITSN/A

Forward P/S (NTM)

HRGNN/A

LITSN/A

Revenue (TTM)

HRGN$982K

LITS$0

Revenue Growth (YoY)

HRGN44.6%

LITSN/A

Forward Rev Growth

HRGN0.0%

LITS0.0%

Gross Margin (TTM)

HRGN7.5%

LITS100.0%

Operating Margin (TTM)

HRGN0.0%

LITS34.9%

EBITDA Margin (TTM)

HRGN-682.9%

LITS0.0%

Net Margin (TTM)

HRGN-680.5%

LITS39.0%

FCF Margin (TTM)

HRGN-370.2%

LITSN/A

Net Income (TTM)

HRGN$-7M

LITS$-34M

FCF (TTM)

HRGN$-4M

LITS$-9M

EPS (TTM)

HRGN-$0.38

LITS$0.00

ROE (TTM)

HRGN-78637.0%

LITS-6886.0%

ROA (TTM)

HRGN-30701.0%

LITS-6748.0%

ROIC (TTM)

HRGN-77233.0%

LITS-6886.0%

Cash

HRGN$351K

LITS$6M

Debt

HRGN$500K

LITS$0

Net Cash/Debt

HRGN$-149K

LITS$6M

Current Ratio (TTM)

HRGN0.26x

LITS5.74x

Quick Ratio (TTM)

HRGN0.12x

LITS5.34x

Debt/Equity (TTM)

HRGN0.00x

LITS0.00x

Debt/Assets (TTM)

HRGN0.0%

LITS0.0%

Interest Coverage (TTM)

HRGNN/A

LITSN/A

Net Debt/EBITDA (TTM)

HRGN0.00x

LITS0.00x

Beta

HRGN-0.50

LITS0.06

52W Performance

HRGN-15.8%

LITS-49.2%

YTD Performance

HRGN16.2%

LITS-17.5%

% from 52W High

HRGN-21.2%

LITS-57.2%

% from 52W Low

HRGN145.8%

LITS84.4%

Asset Turnover (TTM)

HRGN0.45x

LITS0.84x

FCF Yield (TTM)

HRGN-9.0%

LITS-21.1%

Earnings Yield (TTM)

HRGN-16.5%

LITS-79.7%

Dividend Yield (TTM)

HRGNN/A

LITSN/A

Rule of 40

HRGN-325.5

LITS0.0

EV/GP/RG

HRGNN/A

LITSN/A

Ticker research

View HRGN research View LITS research

Metric	HRGN Harvard Apparatus Regenerative Technology Inc	LITS Lite Strategy Inc
Market & Valuation
Market Cap	$40M	$43M
Enterprise Value	$41M	$38M
Price	$2.30	$1.27
P/E Ratio	N/A	N/A
P/S Ratio	41.18x	0.40x
EV/Sales	41.33x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	507.11x	1.01x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.16x	-4.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$982K	$0
Revenue Growth (YoY)	44.6%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.5%	100.0%
Operating Margin (TTM)	0.0%	34.9%
EBITDA Margin (TTM)	-682.9%	0.0%
Net Margin (TTM)	-680.5%	39.0%
FCF Margin (TTM)	-370.2%	N/A
Net Income (TTM)	$-7M	$-34M
FCF (TTM)	$-4M	$-9M
EPS (TTM)	-$0.38	$0.00
ROE (TTM)	-78637.0%	-6886.0%
ROA (TTM)	-30701.0%	-6748.0%
ROIC (TTM)	-77233.0%	-6886.0%
Financial Health
Cash	$351K	$6M
Debt	$500K	$0
Net Cash/Debt	$-149K	$6M
Current Ratio (TTM)	0.26x	5.74x
Quick Ratio (TTM)	0.12x	5.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.50	0.06
52W Performance	-15.8%	-49.2%
YTD Performance	16.2%	-17.5%
% from 52W High	-21.2%	-57.2%
% from 52W Low	145.8%	84.4%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.84x
FCF Yield (TTM)	-9.0%	-21.1%
Earnings Yield (TTM)	-16.5%	-79.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-325.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HRGN research	View LITS research

Valuation

P/S Ratio

LITS

0.40x

HRGN

41.18x

EV/FCF

HRGN

-11.16x

LITS

-4.11x

Growth & revenue

Revenue Growth TTM

HRGN

44.6%

Forward Revenue Growth

HRGN

0.0%

LITS

0.0%

Profitability & performance

Gross Margin

LITS

100.0%

HRGN

7.5%

ROE

LITS

-6886.0%

HRGN

-78637.0%

FCF Yield %

HRGN

-9.0%

LITS

-21.1%

52-Week Performance

HRGN

-15.8%

LITS

-49.2%

Detailed metrics comparison

HRGN

Harvard Apparatus Regenerative Technology Inc

LITS

Lite Strategy Inc

Market Cap

HRGN$40M

LITS$43M

Enterprise Value

HRGN$41M

LITS$38M

Price

HRGN$2.30

LITS$1.27

P/E Ratio

HRGNN/A

LITSN/A

P/S Ratio

HRGN41.18x

LITS0.40x

EV/Sales

HRGN41.33x

LITS0.00x

EV/EBITDA

HRGN0.00x

LITS0.00x

P/B Ratio

HRGN507.11x

LITS1.01x

P/FCF Ratio

HRGNN/A

LITSN/A

EV/FCF

HRGN-11.16x

LITS-4.11x

PEG Ratio

HRGNN/A

LITSN/A

Forward P/E (NTM)

HRGNN/A

LITSN/A

Forward P/S (NTM)

HRGNN/A

LITSN/A

Revenue (TTM)

HRGN$982K

LITS$0

Revenue Growth (YoY)

HRGN44.6%

LITSN/A

Forward Rev Growth

HRGN0.0%

LITS0.0%

Gross Margin (TTM)

HRGN7.5%

LITS100.0%

Operating Margin (TTM)

HRGN0.0%

LITS34.9%

EBITDA Margin (TTM)

HRGN-682.9%

LITS0.0%

Net Margin (TTM)

HRGN-680.5%

LITS39.0%

FCF Margin (TTM)

HRGN-370.2%

LITSN/A

Net Income (TTM)

HRGN$-7M

LITS$-34M

FCF (TTM)

HRGN$-4M

LITS$-9M

EPS (TTM)

HRGN-$0.38

LITS$0.00

ROE (TTM)

HRGN-78637.0%

LITS-6886.0%

ROA (TTM)

HRGN-30701.0%

LITS-6748.0%

ROIC (TTM)

HRGN-77233.0%

LITS-6886.0%

Cash

HRGN$351K

LITS$6M

Debt

HRGN$500K

LITS$0

Net Cash/Debt

HRGN$-149K

LITS$6M

Current Ratio (TTM)

HRGN0.26x

LITS5.74x

Quick Ratio (TTM)

HRGN0.12x

LITS5.34x

Debt/Equity (TTM)

HRGN0.00x

LITS0.00x

Debt/Assets (TTM)

HRGN0.0%

LITS0.0%

Interest Coverage (TTM)

HRGNN/A

LITSN/A

Net Debt/EBITDA (TTM)

HRGN0.00x

LITS0.00x

Beta

HRGN-0.50

LITS0.06

52W Performance

HRGN-15.8%

LITS-49.2%

YTD Performance

HRGN16.2%

LITS-17.5%

% from 52W High

HRGN-21.2%

LITS-57.2%

% from 52W Low

HRGN145.8%

LITS84.4%

Asset Turnover (TTM)

HRGN0.45x

LITS0.84x

FCF Yield (TTM)

HRGN-9.0%

LITS-21.1%

Earnings Yield (TTM)

HRGN-16.5%

LITS-79.7%

Dividend Yield (TTM)

HRGNN/A

LITSN/A

Rule of 40

HRGN-325.5

LITS0.0

EV/GP/RG

HRGNN/A

LITSN/A

Ticker research

View HRGN research View LITS research

Metric	HRGN Harvard Apparatus Regenerative Technology Inc	LITS Lite Strategy Inc
Market & Valuation
Market Cap	$40M	$43M
Enterprise Value	$41M	$38M
Price	$2.30	$1.27
P/E Ratio	N/A	N/A
P/S Ratio	41.18x	0.40x
EV/Sales	41.33x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	507.11x	1.01x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.16x	-4.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$982K	$0
Revenue Growth (YoY)	44.6%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.5%	100.0%
Operating Margin (TTM)	0.0%	34.9%
EBITDA Margin (TTM)	-682.9%	0.0%
Net Margin (TTM)	-680.5%	39.0%
FCF Margin (TTM)	-370.2%	N/A
Net Income (TTM)	$-7M	$-34M
FCF (TTM)	$-4M	$-9M
EPS (TTM)	-$0.38	$0.00
ROE (TTM)	-78637.0%	-6886.0%
ROA (TTM)	-30701.0%	-6748.0%
ROIC (TTM)	-77233.0%	-6886.0%
Financial Health
Cash	$351K	$6M
Debt	$500K	$0
Net Cash/Debt	$-149K	$6M
Current Ratio (TTM)	0.26x	5.74x
Quick Ratio (TTM)	0.12x	5.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.50	0.06
52W Performance	-15.8%	-49.2%
YTD Performance	16.2%	-17.5%
% from 52W High	-21.2%	-57.2%
% from 52W Low	145.8%	84.4%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.84x
FCF Yield (TTM)	-9.0%	-21.1%
Earnings Yield (TTM)	-16.5%	-79.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-325.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HRGN research	View LITS research